Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02936115 · ClinicalTrials.gov registry record · Phase 4
TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers
A Phase 4 study, sponsored by Osiris Therapeutics.
- Terminated
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT02936115: Clinical Trial Phase 4 study, sponsored by Osiris Therapeutics.
NCT02936115 is a Phase 4 study that was terminated before completion, run by Osiris Therapeutics. The registered enrollment target is 14 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02936115, a Phase 4 study, was terminated before completion, sponsored by Osiris Therapeutics.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic diabetic foot ulcers.
Interventions
- OTHER TruSkin®
- OTHER Wound Cover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | Phase 4 |
Why NCT02936115 stopped before completion
NCT02936115 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which TruSkin® is the first listed.
NCT02936115 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02936115 about?
NCT02936115 is a clinical study titled "TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers". The purpose of this study is to compare the clinical outcomes of TruSkin® and an Active Comparator in patients with chronic diabetic foot ulcers.
What is the current status of trial NCT02936115?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02936115?
The interventions under investigation include: TruSkin® (OTHER), Wound Cover (OTHER).
Who is sponsoring clinical trial NCT02936115?
This trial is sponsored by Osiris Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02936115's enrollment target sits among peer trials
14 1901st of 2000 higher than 91 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia